Mike holds a Ph.D. in bioorganic chemistry and has led scientific operations and strategies across biotechnology and pharmaceutical companies. Mike specializes in oligonucleotide, protein/ peptide/lipid nanoparticle-based drug products & delivery formulations and analytical development – setting new standards for quality and compliance in genomic medicine.